Movement Alert｜Stryker Rises 3.03% in Regular Trading, UBS Cuts Rating to Neutral

Market Focus10-22

On October 22, Stryker rose 3.03% in Regular Trading, trading near $306.355 per share, with turnover of $156 million.

The clearest public catalyst tied to the move was a same-day analyst action: UBS downgraded Stryker to Neutral, making the rating change the most time-relevant event linked to the stock's unusual trading activity.

For background, Stryker last reported second-quarter adjusted EPS of $3.69 on revenue of $6.589 billion, both above expectations, and raised its full-year adjusted EPS guidance to $14.95-$15.10. Earlier in August, UBS had lowered its price target to $382 from $400 while maintaining a Buy rating, indicating a more cautious stance had already been developing before the latest downgrade.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment